Financial Data and Key Metrics Changes - For Q4 2025, the company reported worldwide revenue of $1.26 billion, a 13% increase from $1.11 billion in Q4 2024, with organic growth at 12% [15][16] - U.S. revenue reached $892 million in Q4 2025, up 11% from $803 million in Q4 2024 [15] - International revenue grew 18% to $368 million in Q4 2025, with organic growth at 15% [16] - Gross profit for Q4 was $799.8 million, representing 63.5% of revenue, an increase from 59.4% in Q4 2024 [17] - Operating income was $331.5 million, or 26.3% of revenue, compared to $209.5 million, or 18.8% of revenue, in Q4 2024 [18] - Net income for Q4 was $265.1 million, equating to $0.68 per share [18] - The company closed the quarter with approximately $2 billion in cash and cash equivalents, indicating strong financial flexibility [18] Business Line Data and Key Metrics Changes - The rollout of the Dexcom G7 15-day system has received positive feedback, enhancing customer experience and potentially increasing market share [6][12] - The company is focusing on improving customer experience through new digital support systems and AI integration [7][8] - The early access launch of Dexcom Smart Basal aims to improve outcomes for Type 2 diabetes management [8] Market Data and Key Metrics Changes - The international business showed strength, particularly in Germany, the United Kingdom, and France, with France being one of the fastest-growing markets due to Type 2 access expansion [16] - The company anticipates that international market opportunities could surpass those in the U.S. over time [11] Company Strategy and Development Direction - The company aims to be the premier glucose sensing solution, focusing on sensor accuracy, reliability, and connectivity [6] - Strategic priorities include enhancing customer experience, expanding international market share, and driving growth through product innovation [10][11] - The company plans to introduce new products in 2026, including Stelo and a new CGM system for international markets [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in metabolic health management and the impact of upcoming Medicare coverage for Type 2 non-insulin users [24][26] - The company expects total revenue for 2026 to be in the range of $5.16 billion to $5.25 billion, reflecting growth of 11%-13% [19][20] - Management highlighted the importance of maintaining gross margin improvements and operational efficiencies while investing in new facilities [20][47] Other Important Information - The company has surpassed $1 billion in free cash flow for the first time in 2025 [19] - An Investor Day is planned for May 2026 to provide further details on the company's outlook [13] Q&A Session Summary Question: Discussion on the company's glucose sensing journey and market potential - Management believes the company is in the early stages of addressing metabolic health issues, with significant growth opportunities in Type 2 coverage expected in the next 12-24 months [24][26] Question: Inquiry about CMS coverage for Type 2 non-insulin users - Management is optimistic about upcoming CMS coverage decisions and is preparing for potential impacts on market access [30][33] Question: Impact of the 15-day product rollout on margins and new markets - The 15-day product is expected to contribute to margins over time, with significant opportunities for international expansion [36][39] Question: Discussion on operating expenses and investments - Increased operating expenses are primarily due to investments in the new Ireland manufacturing facility, which will enhance future production capabilities [46][47] Question: Utilization rates among different user segments - Utilization rates remain stable across various user segments, with high engagement expected to drive further growth [51][52] Question: Revenue outlook and new patient dynamics for 2026 - Revenue growth will depend on patient retention, utilization, and pricing strategies, with a focus on maintaining a stable user base [56][60] Question: Stability of the U.S. sensor uptake trends - Management noted improvements in sensor deployment and stable user retention, contributing to positive sell-through trends [64][66] Question: Pricing dynamics related to Medicare coverage - Pricing strategies will be influenced by competitive bidding processes, with expectations for stable pricing amidst increased volume [72][74] Question: International market growth strategies - The company plans to deepen its presence in existing markets and expand into new regions, with a focus on generating evidence to support market access [80][82]

Financial Data and Key Metrics Changes - Net income for Q2 2026 increased to $9.4 million, up from $7.1 million in the prior year, reflecting a year-over-year growth of 32.4% [5][17] - Adjusted EBITDA rose to $18.5 million, an increase of $2.4 million year-over-year, with an adjusted EBITDA margin improving to approximately 5% from 4.1% [5][17] - Gross margin expanded by 210 basis points to 12.8%, driven by a favorable product mix and operational discipline [5][16] Business Line Data and Key Metrics Changes - Physical movie revenue increased 33% year-over-year to $114 million, supported by strong demand for premium formats [9] - Collectibles revenue grew 31% year-over-year, reflecting momentum in premium and licensed offerings [11][12] - The gaming hardware segment experienced a decline, with a $24 million drop in revenue, primarily due to supply issues with Microsoft consoles [34][45] Market Data and Key Metrics Changes - The overall net revenue for Q2 2026 was $369 million, down from $394 million in the prior year, attributed to softness in lower-margin categories [16] - For the six months ended December 31, 2025, net revenue was $623 million, essentially flat compared to the prior year, indicating a shift towards higher value products [18][19] Company Strategy and Development Direction - The company is focused on building a business that generates sustainable profitability through higher quality revenue and disciplined growth [6][7] - Strategic partnerships with studios like Paramount and Amazon MGM are expected to enhance the premium physical media portfolio and improve revenue quality [10][26] - The introduction of NState Authentic aims to enhance the collectibles market through technology-enabled trust and authentication [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the durability of the margin profile and the ongoing shift towards premium and exclusive content [25][28] - The company is not providing formal guidance but remains optimistic about the long-term trajectory and profitability discipline [25][28] - There is a focus on scaling the Alliance Authentic initiative and expanding the collectibles portfolio [26][28] Other Important Information - The company ended the quarter with approximately $74 million in working capital, reflecting disciplined inventory and payable management [21] - A new $120 million senior secured revolving credit facility was established, reducing borrowing costs and extending maturity [22][23] Q&A Session Summary Question: Can you talk about your ability to sign additional exclusive deals with studios? - Management is in active conversations with various studios and believes that the recent partnerships position the company as a premier solution for licensing physical DVD products [32] Question: Can you discuss the impact of external forces on gaming hardware revenue? - The gaming hardware segment has been affected by supply issues, particularly with Microsoft, while Nintendo has performed well [34][45] Question: What are your thoughts on strategic M&A opportunities? - The company is constantly in discussions regarding M&A and is optimistic about finding the right opportunities that are financially accretive [37][38] Question: Can you provide an update on music sales trends? - Vinyl and CD sales remain strong, with over 16 million vinyl records and 13 million CDs sold in 2025, indicating continued interest in physical music formats [60][61] Question: What is the expected timeline for the rollout of NState Authentic? - The initial rollout is underway, with expectations for traction in the market as marketing efforts ramp up [53][69]

Financial Data and Key Metrics Changes - Revenues for Q4 2025 were $4.9 million, a significant decrease from $31 million in Q4 2024, primarily due to lower unit sales [13] - Gross profit for Q4 2025 was $1.9 million, or 38.8% of revenues, down from $7.1 million, or 54.2% in Q4 2024, driven by lower sales and higher servicing costs [14] - For the full year 2025, revenues were $27.5 million, compared to $41.8 million in 2024, reflecting a decrease in unit sales [15] - The net loss for 2025 was $7.7 million, or a loss of $0.47 per share, compared to a net income of $6.6 million, or $0.41 per diluted share in 2024 [18] Business Line Data and Key Metrics Changes - The company shipped 14 units in Q4 2025, with 8 in the U.S. and 6 internationally, but did not include sales to its largest customer [24] - The Fair Deal Agreement program saw substantial year-over-year utilization increases, with treatments up more than eightfold and the number of patients treated increasing by over 250% in 2025 [7] Market Data and Key Metrics Changes - International sales were strong in Q4 2025, with shipments to China and a growing demand in Asia, particularly in Taiwan and South Korea [8][28] - The company expects international markets to remain a significant part of its growth strategy, with Brazil and the Middle East also showing potential [29] Company Strategy and Development Direction - The introduction of new CPT codes for SRT and IG-SRT technologies is expected to enhance physician reimbursement and support broader adoption of non-invasive treatments [4] - The company aims to achieve full-year profitability in 2026, supported by a diversified customer base and expanding international opportunities [9] - A disciplined approach to scaling the sales organization is being implemented, with plans to hire additional sales representatives to enhance market education and lead conversions [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about entering 2026 with improved clarity and control over the business, emphasizing the positive impact of new reimbursement codes [20] - The company is focused on converting interest into system placements as the year progresses, with expectations for Q1 revenues to exceed Q4 levels [19] Other Important Information - The company ended 2025 with $22.1 million in cash and cash equivalents, with no outstanding debt, indicating a strong balance sheet [18] - Research and development expenses for 2025 increased to $7.8 million, reflecting higher costs related to billing and reimbursement efforts [17] Q&A Session Summary Question: Does the revenue growth guidance for Q1 assume no contribution from the largest customer? - Management confirmed that projections for 2026 exclude expectations from the largest customer, and any contribution from them would be considered upside [24] Question: What is the status of the TDI program and expected FDA approval? - Management indicated ongoing efforts with the FDA but could not provide a timeline for approval [26] Question: What is the demand outlook internationally for 2026? - Management highlighted strong demand in China and growth in Taiwan, with expectations for expansion in South Korea, Japan, and potential entry into Brazil and the Middle East [28][29] Question: How has the reaction to reimbursement affected system mix and financing options? - Management noted a shift towards outright purchases and leasing options due to guaranteed reimbursements, with a stronger focus on SRT products [38][40] Question: What is the outlook for service revenue? - Service revenue remains consistent at about 10% of total revenue, with no expected changes [48]

Financial Data and Key Metrics Changes - In Q4 2025, total revenue was $16 million, a 4% increase year-over-year, while full-year revenue reached $56.7 million, reflecting a 10% growth [3][17] - Gross profit for Q4 was $13.8 million, an 8% increase, with gross margin rising to 86% from 83% a year ago [19] - Net loss for Q4 was $11.9 million, or $0.46 per share, compared to a net loss of $10.7 million, or $0.43 per share in Q4 2024 [21] Business Line Data and Key Metrics Changes - U.S. revenue was $14.9 million in Q4 2025, a 4% increase, with revenue units totaling 478, up from 460 in the prior year [17] - European revenue increased to $1.1 million, a 10% rise, with revenue units growing to 49 from 41 [18] Market Data and Key Metrics Changes - The addressable market for Barostim therapy is estimated at $10.5 billion, with only 1% penetration, indicating significant growth potential [5] - The initiation of the BENEFIT-HF trial could expand the addressable market to approximately $30 billion if successful [12] Company Strategy and Development Direction - The company focused on three strategic priorities: building a world-class sales organization, driving deep adoption in targeted centers, and reducing barriers to adoption [6] - Transition to Category I CPT codes is expected to improve patient access and reimbursement predictability, effective January 1, 2026 [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sales team's ability to execute and drive growth, despite a natural ramp-up period for new sales representatives [6][15] - The company anticipates total revenue for 2026 to be between $63 million and $67 million, with a gross margin of 84% to 86% [23] Other Important Information - The company amended its debt facility to extend the maturity date to 2031 and increase access to additional capital [14][22] - A new Chief Human Resources Officer was appointed, indicating ongoing organizational development [16] Q&A Session Summary Question: On the BENEFIT-HF trial strategy and revenue generation - Management indicated that the trial will involve a mix of existing and new commercial sites, with expected revenue from approximately 1,600 to 1,700 devices sold during the trial [26][28] Question: Growth of active accounts in Q4 - Management noted that while there was a net addition of accounts, the focus remains on deepening existing relationships, with expectations of adding around three active territories quarterly in 2026 [30][31] Question: Impact of the Category I code on treatment barriers - Management reported positive early signs of improved prior authorization approvals and expects this trend to continue as the transition progresses [36][39] Question: Path to profitability and cash management - The company has sufficient cash reserves and access to additional capital, with a focus on driving sales productivity to achieve profitability [72][74]

Financial Data and Key Metrics Changes - In Q4 2025, Expedia Group reported an 11% increase in bookings and revenue, with EBITDA margin expansion of nearly 4 points [14][20] - Gross bookings reached $27 billion, while revenue was $3.5 billion, with foreign exchange contributing slightly over 1 point to bookings growth and about 2 points to revenue [16][20] - Adjusted EBITDA for Q4 was $848 million, with a margin of 24%, reflecting revenue growth and expense leverage [19] Business Line Data and Key Metrics Changes - B2C gross bookings grew 5% to $18.3 billion, while B2C revenue increased 4% [16] - B2B gross bookings surged 24% to $8.7 billion, with revenue also growing 24% to $1.3 billion [17] - B2C EBITDA margins improved to 31.5%, up approximately 6 points from the previous year, driven by marketing leverage [16] Market Data and Key Metrics Changes - Booked room nights increased by 9%, with high single-digit growth in the U.S. and low double-digit growth in EMEA and the rest of the world [4][15] - Consumer spending remained robust, with longer booking windows and lengths of stay compared to 2024 [4] - The B2B segment experienced double-digit growth across all regions, indicating strong market demand [8] Company Strategy and Development Direction - The company aims to enhance traveler value through improved product offerings, faster site performance, and personalized experiences using AI [5][10] - Investments are being made in new lines of business, including the acquisition of Tiqets to broaden offerings for partners and travelers [9] - The strategy includes driving operational efficiencies and margin expansion, with a focus on optimizing marketing spend and leveraging AI for better targeting [12][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and ability to execute, anticipating continued growth and margin expansion in 2026 [13][24] - The company is cautious about macroeconomic uncertainties but expects strong bookings momentum entering Q1 2026 [20][21] - Management highlighted the importance of maintaining a competitive edge through enhanced customer service and loyalty programs [84] Other Important Information - The company ended Q4 with $5.7 billion in unrestricted cash and short-term investments, maintaining a commitment to return capital to shareholders [20] - A quarterly dividend increase of 20% to $0.48 per share was announced [20] Q&A Session Summary Question: Enhancements in Travel Planning Process - Management emphasized the importance of personalized marketing and product features to capture travelers earlier in the planning process [26][27] Question: B2C Marketing Leverage - Management discussed achieving about 50 basis points of leverage in B2C marketing through improved efficiency and targeting [30][31] Question: Competitive Positioning of Consumer Brands - Management expressed confidence in the positioning of their brands, highlighting improvements in supply and marketing effectiveness [36][38] Question: Margin Trajectory Outlook - Management indicated confidence in future margin expansion driven by effective execution and growth in B2C and B2B segments [42][44] Question: Supply Growth Dynamics - Management confirmed that supply growth benefits both B2C and B2B segments, with ongoing efforts to onboard properties more efficiently [49][51] Question: Traffic Changes from Google AI Features - Management noted no material changes in traffic from Google but sees opportunities in AI search to better target travelers [55][56] Question: B2B Growth Drivers - Management highlighted strong double-digit growth in B2B, driven by deeper partner relationships and innovative product offerings [62][65] Question: Alternative Lodging Uptake - Management reported growth in alternative lodging on Brand Expedia, indicating ongoing efforts to enhance the user experience [78] Question: CapEx for 2026 - Management expects CapEx to remain roughly in line with previous years, indicating no significant changes [79]

Financial Data and Key Metrics Changes - Revenue for the second fiscal quarter of 2026 was $14.1 million, up from $13.2 million in the prior quarter, but down from $16.8 million in the same quarter last year [16] - Gross margin increased to 34.7% from 28.6% in the prior quarter and 32.5% in the prior year, reflecting improved product mix and cost-saving initiatives [16] - Operating expenses decreased to $4.1 million from $5.9 million in the prior quarter and $6.9 million in the same quarter of 2025, a 31% sequential decrease [17] - Net income for the second quarter was $0.6 million, or $0.03 per share, compared to a net loss of $2.6 million in the prior quarter [17] - Adjusted EBITDA for the second quarter was positive $1.5 million, compared to an adjusted EBITDA loss of $1.4 million in the prior quarter [18] Business Line Data and Key Metrics Changes - The company achieved net profitability for the first time in its history, attributed to expense optimization and sequential revenue growth [4][12] - The product development team made significant progress, particularly with the launch of the next-generation SkyLink telematics device [9] - The new GAT 315 battery was released in response to customer demand in the GSE segment, expanding the product line to four with multiple configurations [10] Market Data and Key Metrics Changes - The lithium-ion forklift battery segment is projected to grow at an 8.8% CAGR through 2035, indicating strong long-term market opportunities [15] - The company is experiencing a capital freeze from its most significant customer, which may impact revenue for a significant portion of calendar year 2026 [13] Company Strategy and Development Direction - The company focuses on five strategic initiatives: profitable growth, operational efficiencies, solution selling, building the right products, and integrating value-added software [5] - The integration of AI-driven tools in engineering design and operations aims to improve operational efficiencies and productivity [6] - The company is expanding its sales leadership and hiring experienced personnel to enhance customer engagement and drive growth [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate current market pressures and restore profitable growth despite the capital freeze from a key customer [14] - The management team is focused on reducing expenses and optimizing operations to maintain profitability [15] - There is cautious optimism regarding demand, with customers needing to purchase batteries to sustain their operations despite tariff impacts [24] Other Important Information - The company recorded a $0.5 million reversal of previously accrued employee bonus awards, which will not impact future quarters [17][45] - The SkyEMS software was upgraded to include intelligent alerting features, which are expected to improve fleet management and productivity [11] Q&A Session Summary Question: Is the capital freeze unique to one customer or indicative of broader industry trends? - Management confirmed that the capital freeze is specific to one customer [23] Question: How is the overall demand environment characterized? - Management noted that while tariff effects linger, customers still need to purchase batteries to run their businesses [24] Question: What is the rollout strategy for the SkyLink product? - The SkyLink telematics will be offered across the product line, with positive initial feedback from beta tests [25][26] Question: Will cost savings and warranty costs remain low to support gross margins? - Management indicated that they are taking steps to lower product costs and expect positive trends in warranty and repair costs [29][31] Question: What is the strategy for filling the revenue gap from the significant customer? - The company is actively hiring new sales personnel and focusing on material handling to replace lost revenue [36] Question: Will new SkyLink features be sold at a premium? - Management plans to offer a standard and a premium version of the software, with higher gross margins expected from premium sales [38][39] Question: Can you elaborate on the State of Health patent and its revenue potential? - The patent includes algorithms for battery health insights, which will be part of the premium software package, generating potential revenue [40][41]

Financial Data and Key Metrics Changes - Revenue grew 40.7% year-over-year to $19.2 million, marking the fourteenth consecutive quarter of double-digit revenue growth [6][7] - Adjusted EBITDA increased 61.6% to $3 million, reflecting scale and effective cost management [7][14] - Net income rose 46% to $2 million, or $0.15 per diluted share, up from $0.10 in the prior year quarter [7][15] - Year-to-date revenue for six months increased 39.6% to $38.6 million [17] Business Line Data and Key Metrics Changes - New student starts increased by 49.4% to 593 from 397 last year, driven by strong enrollment and disciplined marketing execution [14][15] - The company launched new programs, including MRI and cardiac sonography, contributing to enrollment growth [8][10] Market Data and Key Metrics Changes - The healthcare occupation sector is projected to be the fastest-growing major industry from 2024 to 2034, with about 1.9 million openings projected each year [5][6] - The aging population and expanded access to care are driving demand for skilled human expertise in healthcare [6] Company Strategy and Development Direction - The company is focused on scaling quality, improving outcomes, and training job-ready graduates for essential roles in healthcare [5][6] - Strategic priorities include sustained enrollment growth, curriculum expansion, and operational innovation [20][21] - The company is pursuing additional regulatory approvals and exploring both organic expansion and acquisitions [22][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate regulatory changes and maintain strong compliance [24] - The company is positioned for continued investment in growth, with a strong balance sheet and positive operating cash flow [25][24] Other Important Information - The company received reaccreditation for its Integrity College of Health campus, reflecting confidence in its academic delivery and student outcomes [10] - The integration of Contra Costa Medical Career College is complete, with enrollment reaching all-time highs [10] Q&A Session Summary Question: Discussion on new student starts - Management noted that the increase in new student starts was driven by additional cohorts in hybrid programs and strong performance in vocational nursing [27][30] Question: Outlook on new programs - Management confirmed that new programs starting in Q3 and Q4 are expected to support 20-30 student cohorts, with recurring starts every 3-6 months [35][36] Question: M&A activity and pipeline - Management indicated that they are exploring acquisition opportunities both within and outside California, with a goal to announce a deal within the fiscal year [36][44] Question: Hybrid program student commitments - Management stated that students in hybrid programs are primarily full-time, benefiting from the flexibility of online learning combined with in-person lab sessions [47][48] Question: Revenue per student increase - Management explained that the increase in revenue per student is attributed to more students entering higher-margin programs and the timing of revenue recognition [52]

Financial Data and Key Metrics Changes - In Q4 2025, total revenue reached $20.1 million, a 30% year-over-year increase and 16% sequential growth, exceeding guidance [20] - For the full year 2025, total revenue was $70.6 million, representing a 22% increase year-over-year [20] - Annual contract value plus royalties hit a record $83.6 million, up 28% year-over-year [21] - Remaining performance obligations (RPO) totaled $117 million, a 32% year-over-year increase, with approximately half expected to be recognized as revenue in 2026 [21] - Non-GAAP gross profit for Q4 was $18.5 million, with a gross margin of 92% [22] - Non-GAAP operating loss for Q4 was $2.2 million, while the full year loss was $12.5 million, an improvement over the previous year [25] Business Line Data and Key Metrics Changes - The company reported a significant increase in variable royalties, which were 50% higher year-over-year, with Q4 setting a new record [20] - The number of large royalty reporters tripled over the last two years, contributing to a balanced mix of customers across vertical markets [20] - FlexGen, an AI-driven smart NoC IP product, saw strong adoption with over 30 production device deployments [11] - Ncore, a cache coherent interconnect IP product, also experienced strength in licensing across various applications [12] Market Data and Key Metrics Changes - The company noted expanding demand for AI-driven semiconductor designs across various markets, including enterprise computing, automotive, and consumer electronics [6] - The number of chiplet projects incorporating Arteris technology has more than tripled over the past two years, indicating strong market growth [15] - The automotive segment remains the largest vertical market, with emerging strength in consumer and aerospace sectors [39] Company Strategy and Development Direction - The acquisition of Cycuity enhances the company's product portfolio by adding cybersecurity assurance products, addressing market concerns about increasing cyberattacks [8][9] - The company aims to leverage its technology to improve hardware security and vulnerability testing across all SoCs, expanding its customer base [10] - Arteris is focusing on supporting semiconductor applications in the AI era, with a strong position in various sectors including autonomous vehicles and industrial automation [17] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, expecting to report a non-GAAP operating profit as early as Q4 2026 [28] - The company anticipates continued strong demand for its products driven by the rise of AI and the need for efficient data movement in semiconductors [6] - Management highlighted the importance of addressing cybersecurity in semiconductor designs, which is becoming a critical issue in the industry [30] Other Important Information - The company ended the year with $59.5 million in cash and no financial debt, with positive free cash flow of $3 million for Q4 [26] - The guidance for Q1 2026 includes expected ACV plus royalties of $85 million-$89 million and revenue of $20.5 million-$21.5 million [27] Q&A Session Summary Question: Cross-sell opportunities and customer segments - Management indicated that hardware security assurance is a growing issue, and the acquisition opens significant opportunities to enhance system IP value across various semiconductor companies [30][31] Question: NXP announcement and customer interest - Management confirmed that NXP is now using four solutions, indicating increased interest in deploying a full suite of solutions, which could drive average selling prices above $1 million [36] Question: Strength in royalties and market segments - Management noted that the growth in royalties is attributed to both customer diversification and an increase in large royalty reporters across various segments, including automotive and consumer markets [38][39] Question: Impact of security on P&L - Management clarified that approximately $7 million of the projected revenue for 2026 is expected from the Cycuity acquisition, with a slight contribution to operating loss anticipated [47] Question: Equity raising efforts post-acquisition - Management stated that they are in the process of activating an ATM for equity raising, with expectations for small amounts to be raised in the first quarter [49]

Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $376.9 million, up 12% year-over-year, with subscription revenue at $261.4 million, up 15% year-over-year [11][12] - Adjusted operating income for Q4 was $45 million, up 26% from the previous year, with a subscription adjusted operating margin of 16.5%, an increase from 15.3% [13][15] - Free cash flow for the full year of 2025 increased to $75.4 million, representing 5.2% of total revenue, a 95% year-over-year increase [16] Business Line Data and Key Metrics Changes - Subscription pets increased by 5% year-over-year to over 1,096,000 pets, including approximately 63,000 pets in Europe [11] - Adjusted operating income from the subscription business was $43.1 million, contributing 96% of total adjusted operating income for the quarter [13] - Revenue from other business segments was $115.4 million for the quarter, a 5% year-over-year increase, but expected to decelerate due to no new pet enrollments in most U.S. states [14] Market Data and Key Metrics Changes - Average monthly retention for the trailing twelve months was 98.34%, an increase from 98.25% in the previous year [11] - The veterinary channel remains critical for distribution, with nearly 200 territory partners educating pet parents about the value of medical insurance [9] Company Strategy and Development Direction - The company plans to invest aggressively in pet acquisition and retention strategies to strengthen the Trupanion brand in more households [20] - The objective of the new strategic plan is to deliver sustainable growth in adjusted operating income and intrinsic value creation [21] - The company is exploring a lower-priced insurance plan to address the needs of pet owners facing tighter budgets [46] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business model's resilience and the ability to fund growth through strong financial performance [21] - The company expects total revenue for 2026 to be in the range of $1.55 billion to $1.582 billion, with subscription revenue growth projected at approximately 14% year-over-year [17] - Management is closely monitoring veterinary inflation and expects it to remain in line with current trends [18][58] Other Important Information - The company ended 2025 with $370.7 million in cash and short-term investments, and a total debt balance of $111.8 million, a reduction of $17.1 million from the previous year [16] - Non-cash expenses included $9.4 million in stock-based compensation and a $1.1 million goodwill impairment charge related to European businesses [15] Q&A Session Summary Question: Can you talk about some successes in reaching pet parents and how that will be accelerated going forward? - Management highlighted that brand spend is focused on increasing visibility among pet parents, particularly in the veterinary space, leading to quicker conversions and encouraging results [24][26] Question: Was there any favorable reserve development in the loss ratio reported? - Management noted a slight adverse development of about 30 basis points, but expressed satisfaction with the overall loss ratio improvement [27][28] Question: Can you provide insights on the 2026 guidance regarding gross adds and commercial strategy? - Management indicated that pricing will continue to be a dominant contributor to revenue growth, with expectations for increased gross adds and diligent expense management leading to margin expansion [30][31] Question: Can you discuss the retention improvements and where they are coming from? - Management confirmed that retention is improving across all cohorts, with specific improvements noted in those receiving rate increases of under 20% [35][36] Question: What updates can you provide on the go-to-market strategy for a lower-priced plan? - Management is working on broadening the existing Trupanion offering and developing a new product that will address market gaps, with plans to leverage brand trust in the veterinary industry [46][47]

Financial Data and Key Metrics Changes - In Q4 2025, revenue declined by 7% year-over-year to $101.1 million, while full-year revenue decreased by 8% to $396.9 million compared to $432.5 million in 2024 [20][29] - Free cash flow for 2025 was approximately $18 million, with client retention reaching 87%, up from the start of 2025 [10][19] - Net income for Q4 decreased by 53% to $3.2 million, with earnings per share at $0.17, while full-year net income decreased by 21% to $22.2 million [29][32] Business Line Data and Key Metrics Changes - Research segment revenue for Q4 was $76.6 million, down 4%, and $295.6 million for the full year, down 7% [26] - Consulting revenue for Q4 was $21.8 million, down 16%, and $88.2 million for the full year, down 9% [26] - Events revenue for Q4 was $2.7 million, down 1%, and for the full year, it declined by 29% to $13.1 million [27] Market Data and Key Metrics Changes - Client count increased in Q4 for the first time since Q4 2021, reflecting a positive trend in client engagement [10][25] - The percentage of contract value (CV) from multi-year deals increased to 72% at year-end, up from 69% in Q4 2024 [10] Company Strategy and Development Direction - The company plans to return to CV growth in 2026 by focusing on four initiatives: improving retention lifecycle, introducing more product options, fostering a culture of growth in sales, and producing actionable research [11][19] - A restructuring affecting 8% of employees was announced to align costs with revenue and focus on expanding research contract value [17][21] - The strategy consulting business will be exited due to ongoing instability and competition, while advisory and content marketing services will continue [21][22] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges in Q4 and 2025 due to macroeconomic uncertainty and the impact of U.S. government consulting pullbacks [20][32] - The company sees opportunities in the AI landscape, emphasizing the importance of proprietary data and human expertise in their offerings [9][58] - Management expressed optimism about the performance of the new AI Access product, which exceeded expectations with over $5 million in bookings since its launch [11][70] Other Important Information - The company is investing in AI to enhance its research capabilities and improve client engagement [19][32] - A new event strategy will focus on smaller, localized events to better meet client needs [18][52] Q&A Session Summary Question: Can you elaborate on the consulting restructure and expected revenue impact? - The revenue impact from sunsetting strategy consulting is approximately $6 million, with a backlog of about $8 million to service throughout 2026 [37] Question: What are the reasons for lower wallet retention? - There is ongoing volatility in the U.S. government sector and some uncertainty in the U.S. business, but there are positive trends in international markets [39][40] Question: Can you discuss the product pipeline for 2026? - The company is looking to provide more ways for clients to buy and embed Forrester's offerings into their daily work, with several exciting products scheduled for release [47][48] Question: How is AI Access performing compared to expectations? - AI Access exceeded expectations in Q4, significantly improving deal cycle times and increasing client count, particularly with new clients [70][80]